Table 3.
Characteristics | Training set | External Validation set 1 | External Validation set 2 | |||
---|---|---|---|---|---|---|
AUC | 95% CI | AUC | 95% CI | AUC | 95% CI | |
Radiomics signature | 0.836 | 0.754 ~ 0.917 | 0.811 | 0.669 ~ 0.952 | 0.822 | 0.701 ~ 0.943 |
MPD size | 0.791 | 0.683 ~ 0.899 | 0.747 | 0.572 ~ 0.923 | 0.793 | 0.647 ~ 0.939 |
Largest cyst size | 0.613 | 0.486 ~ .0740 | 0.705 | 0.519 ~ 0.891 | 0.681 | 0.516 ~ 0.846 |
Enhancing mural nodule | 0.614 | 0.484 ~ 0.744 | 0.732 | 0.548 ~ 0.915 | 0.686 | 0.517 ~ 0.855 |
CA19–9 > 37kU/L | 0.730 | 0.608 ~ 0.852 | 0.758 | 0.576 ~ 0.940 | 0.767 | 0.604 ~ 0.931 |
MPD Main pancreatic duct, AUC Area under the receiver operating characteristic (ROC) curve, CI Confidence internal